Market Place
Sourcing Support
Alvotech Announces A Change In Its Executive Team
30 Apr 2026 //
FIRSTWORD PHARMA
Transactions of Managers and Closely Associated Persons
26 Feb 2026 //
GLOBENEWSWIRE
Managers Disclose Deals with Close Associates
07 Jan 2026 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
06 Jan 2026 //
GLOBENEWSWIRE
Alvotech Plans CEO Succession For Leadership Transition
06 Jan 2026 //
GLOBENEWSWIRE
Company Updates Own Shares Holdings
29 Dec 2025 //
GLOBENEWSWIRE
Alvotech Reports 9-Month 2025 Results & Business Update
12 Nov 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
23 May 2025 //
GLOBENEWSWIRE
Alvotech`s Shares Trade on Nasdaq Stockholm Today
19 May 2025 //
GLOBENEWSWIRE
Alvotech Appoints DNB Carnegie for Nasdaq Stockholm Liquidity
19 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
16 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
13 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
09 May 2025 //
GLOBENEWSWIRE
Alvotech Publishes Prospectus for Nasdaq Stockholm listing
08 May 2025 //
GLOBENEWSWIRE
Alvotech Reports Q1 2025 Results and Business Update
07 May 2025 //
GLOBENEWSWIRE
Alvotech Reports Record 2024 Results and Business Update
26 Mar 2025 //
GLOBENEWSWIRE
Alvotech to Report 2024 Financial Results on March 26, 2025
24 Feb 2025 //
GLOBENEWSWIRE
Alvotech Reports 2024 Results for First Nine Months Again
13 Nov 2024 //
GLOBENEWSWIRE
Alvotech Reports 2024 Results for First Nine Months
13 Nov 2024 //
GLOBENEWSWIRE
Alvotech To Report H1 2024 Results On August 15
01 Aug 2024 //
GLOBENEWSWIRE
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In Europe
23 Jul 2024 //
PHARMABIZ
Alvotech Announces Closing of Private Debt Financing
11 Jul 2024 //
GLOBENEWSWIRE
Alvotech Reports Positive Results For AVT03, Biosimilar To Prolia And Xgeva
02 Jul 2024 //
GLOBENEWSWIRE
Alvotech Announces Record Q2 2024 Preliminary Revenue And EBITDA
01 Jul 2024 //
GLOBENEWSWIRE
Alvotech Issues New Shares to Holders of Convertible Bonds
01 Jul 2024 //
GLOBENEWSWIRE
Alvotech Receives Conversion Notices for Majority of Convertible Bonds
26 Jun 2024 //
GLOBENEWSWIRE
Alvotech and STADA add to strategic alliance through denosumab partnership
12 Jun 2024 //
PRESS RELEASE
Alvotech Reports Q1 2024 Results, Provides Business Update
21 May 2024 //
GLOBENEWSWIRE
Alvotech S.A. Annual General Meeting to be held June 7, 2024
15 May 2024 //
GLOBENEWSWIRE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
25 Apr 2024 //
REUTERS
Alvotech and Teva gain FDA approval of Selarsdi for psoriasis
17 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
Alvotech Reports Financial Results for Full Year 2023
20 Mar 2024 //
GLOBENEWSWIRE
Alvotech Announces Webcast of Full Year 2023 Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Alvotech Appoints Interim Chief Quality Officer
29 Feb 2024 //
PRESS RELEASE
Alvotech Announces Positive Results from a Pharmacokinetic Study for AVT03
29 Jan 2024 //
PRESS RELEASE
Transactions of Managers and Closely Associated Persons
24 Jan 2024 //
PRESS RELEASE
Alvotech Announces Positive Results from a Pharmacokinetic Study for AVT05
29 Nov 2023 //
GLOBENEWSWIRE
Alvotech Reports Financial Results for First Nine Months of 2023
28 Nov 2023 //
GLOBENEWSWIRE
Alvotech and Islandsbanki enter into Market Making Agreement
05 Oct 2023 //
GLOBENEWSWIRE
Alvotech ReportsFYR for First Six Months of 2023 and Provides Business Update
30 Aug 2023 //
GLOBENEWSWIRE
Alvotech Issues Annual Equality Report Covering 2022
15 May 2023 //
GLOBENEWSWIRE
Alvotech S.A. Annual General Meeting to be held June 6, 2023
05 May 2023 //
GLOBENEWSWIRE
Sarah Tanksley Joins Board of Directors for Alvotech
19 Apr 2023 //
GLOBENEWSWIRE
Alvotech Provides Update on Corporate Sustainability Framework
28 Mar 2023 //
GLOBENEWSWIRE
Alvotech Reports Financial Results for FY2022 and Provides Business Update
01 Mar 2023 //
GLOBENEWSWIRE
Alvotech Announces Webcast of 2022 Full Year Financial Results
27 Feb 2023 //
GLOBENEWSWIRE
Updated market making agreement with Landsbankinn for Alvotech shares trading
14 Feb 2023 //
GLOBENEWSWIRE
Settlement of Alvotech Private Share Placement Completed
10 Feb 2023 //
GLOBENEWSWIRE
Alvotech Completes $137 Million Private Share Placement
23 Jan 2023 //
GLOBENEWSWIRE
FDA sets decision date for Alvotech’s Humira biosimilar
23 Dec 2022 //
BIOPHARMADIVE
Alvotech Completes $59.7 Million Private Placement
16 Dec 2022 //
GLOBENEWSWIRE
Correction to Total Amount in Announcement About Private Placement Published
16 Dec 2022 //
GLOBENEWSWIRE
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
08 Dec 2022 //
GLOBENEWSWIRE
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
07 Dec 2022 //
GLOBENEWSWIRE
Nasdaq Iceland Approves the Request for Trading of Alvotech’s Shares
02 Dec 2022 //
GLOBENEWSWIRE
Alvotech Announces Changes to its Leadership Team
01 Dec 2022 //
GLOBENEWSWIRE
Alvotech Submits its Application for Admission of the Company’s Shares
30 Nov 2022 //
GLOBENEWSWIRE
Alvotech Secures Financing Facilities of Approximately $136 Million
16 Nov 2022 //
GLOBENEWSWIRE
Alvotech Reports Financial Results for First Nine Months of 2022
15 Nov 2022 //
GLOBENEWSWIRE
Alvotech Announces Australian MKT Authorization AVT02, a Biosimilar to Humira®
14 Nov 2022 //
GLOBENEWSWIRE
